Skip to main content
SpringerLink
Log in

Oral chemotherapy prescription safety practices in Europe

  • Commentary
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bourmaud A, Pacaut C, Melis A, Tinquaut F, Magne N, Merrouche Y, et al. Is oral chemotherapy prescription safe for patients? A cross-sectional survey. Ann Oncol. 2014;25:500–4.

    CAS  Google Scholar 

  2. Conde-Estevez D, Salas E, Albanell J. Survey of oral chemotherapy safety and adherence practices of hospitals in Spain. Int J Clin Pharm. 2013;35:1236–44.

    Article  PubMed  CAS  Google Scholar 

  3. Weingart SN, Flug J, Brouillard D, Morway L, Partridge A, Bartel S, et al. Oral chemotherapy safety practices at US cancer centres: questionnaire survey. BMJ. 2007;334:407.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Keely JL. Pharmacist scope of practice. Ann Intern Med. 2002;136:79–85.

    Article  PubMed  Google Scholar 

  5. Colomer R, Alba E, Gonzalez-Martin A, Paz-Ares L, Martin M, Llombart A, et al. Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM). Ann Oncol. 2010;21:195–8.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Dr. Aurelie Bourmaud for providing further information about the role of community pharmacists and the dispensing of oral chemotherapy in France. The study of reference is an initiative born in a consolidated group of hospital pharmacists who work to improve quality of oncohematological care, the Spanish Group for the Development of Oncological Pharmacy (GEDEFO, Grupo Español para el Desarrollo de la Farmacia Oncológica).

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of Pharmacy, Hospital Universitari del Mar, Passeig Marítim 25–29, E-08003, Barcelona, Spain

    David Conde-Estévez

  2. Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain

    David Conde-Estévez & Joan Albanell

  3. Department of Medical Oncology, Hospital del Mar, Barcelona, Spain

    Joan Albanell

  4. Pompeu Fabra University, Barcelona, Spain

    Joan Albanell

Authors
  1. David Conde-Estévez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joan Albanell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David Conde-Estévez.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Conde-Estévez, D., Albanell, J. Oral chemotherapy prescription safety practices in Europe. Int J Clin Pharm 36, 863–864 (2014). https://doi.org/10.1007/s11096-014-0002-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-014-0002-2

Keywords

Search

Navigation